Raymond James & Associates’s Health Catalyst HCAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20,659	Closed	-$200K	–	3980
2022 Q3	$200K	Sell	20,659 -7,228	-26%	-$95.7K	﹤0.01%	3443
2022 Q2	$404K	Sell	27,887 -1,283	-4%	-$21.9K	﹤0.01%	3042
2022 Q1	$762K	Sell	29,170 -70,469	-71%	-$2M	﹤0.01%	2780
2021 Q4	$3.95M	Sell	99,639 -19,363	-16%	-$882K	﹤0.01%	1706
2021 Q3	$5.95M	Buy	119,002 +8,387	+8%	+$457K	0.01%	1386
2021 Q2	$6.14M	Buy	110,615 +4,173	+4%	+$222K	0.01%	1353
2021 Q1	$4.98M	Buy	106,442 +9,395	+10%	+$455K	0.01%	1428
2020 Q4	$4.22M	Sell	97,047 -1,190	-1%	-$43.9K	﹤0.01%	1437
2020 Q3	$3.6M	Buy	98,237 +32,987	+51%	+$1.12M	﹤0.01%	1403
2020 Q2	$1.9M	Buy	65,250 +53,420	+452%	+$1.48M	﹤0.01%	1763
2020 Q1	$309K	Buy	+11,830	New	+$361K	﹤0.01%	2744